AI-based analysis identifies the most impactful policy and resource factors for improving cancer survival across 185 countries.
Key Details
- 1Researchers used machine learning to analyze cancer incidence and mortality data from 185 countries.
- 2Study incorporated metrics on radiotherapy access, health system structure, and economic indicators.
- 3Radiotherapy access, universal health coverage, and national wealth repeatedly emerged as top factors for improved survival.
- 4The SHAP-based model provides country-specific roadmaps for policy investment priorities.
- 5An interactive tool allows users to view and compare readiness or gaps for their own country.
- 6The study is published in Annals of Oncology (Jan 2026).
Why It Matters
Radiotherapy access is a major imaging-related determinant of cancer outcomes globally; this AI-driven framework offers targeted, actionable guidance to policymakers and health leaders, promising more efficient allocation of imaging and treatment resources.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.